Blonder Tongue Laboratories, Inc. [NYSE:BDR]: Analyst Rating and Earnings

Professional stock traders oftentimes make sure they verify what some leading Wall Street voices have to say about a potential buy. Its stock price has been found in the range of 3.93 to 6.30. This is compared to its latest closing price of $1.14.

Keep on the lookout for this organization’s next scheduled financial results, which are expected to be made public on Mon 1 Apr (In 50 Days).

Fundamental Analysis of Blonder Tongue Laboratories, Inc. [BDR]

Now let’s turn to look at profitability: with a current Operating Margin for Blonder Tongue Laboratories, Inc. [BDR] sitting at +1.99 and its Gross Margin at +38.17, this company’s Net Margin is now -1.60%. These metrics indicate that this company is not generating as much profit, after accounting for expenses, compared to its market peers.

This company’s Return on Total Capital is 3.50, and its Return on Invested Capital has reached 33.00%. Its Return on Equity is -5.51, and its Return on Assets is -2.55. These metrics suggest that this Blonder Tongue Laboratories, Inc. does a poor job of managing its assets, and likely won’t be able to provide successful business outcomes for its investors in the near term.

Turning to investigate this organization’s capital structure, Blonder Tongue Laboratories, Inc. [BDR] has generated a Total Debt to Total Equity ratio of 87.06. Similarly, its Total Debt to Total Capital is 46.54, while its Total Debt to Total Assets stands at 42.53. Looking toward the future, this publicly-traded company’s Long-Term Debt to Equity is 50.16, and its Long-Term Debt to Total Capital is 26.81. This company has a healthy balance between its debt and its current holdings, suggesting it is a reliable investment due to its ability to leverage debt in an efficient way.

What about valuation? This company’s Enterprise Value to EBITDA is 14.85 and its Total Debt to EBITDA Value is 5.84. The Enterprise Value to Sales for this firm is now 0.75, and its Total Debt to Enterprise Value stands at 0.57. Blonder Tongue Laboratories, Inc. [BDR] has a Price to Book Ratio of 0.67.

Shifting the focus to workforce efficiency, Blonder Tongue Laboratories, Inc. [BDR] earns $199,000 for each employee under its payroll. Similarly, this company’s Receivables Turnover is 9.51 and its Total Asset Turnover is 1.54. This publicly-traded organization’s liquidity data is also interesting: its Quick Ratio is 0.88 and its Current Ratio is 2.27. This company, considering these metrics, has a healthy ratio between its short-term liquid assets and its short-term liabilities, making it a less risky investment.

Performance Indicators

Let’s now turn our attention to trading performance: Blonder Tongue Laboratories, Inc. [BDR] has 9.72M shares outstanding, amounting to a total market cap of $10.59M. Its stock price has been found in the range of 0.52 to 2.20. At its current price, it has moved by -50.45% from its 52-week high, and it has moved 109.62% from its 52-week low.

This stock’s Beta value is currently 1.97, which indicates that it is more volatile that the wider market. This stock’s Relative Strength Index (RSI) is at 48.03. This RSI score is good, suggesting this stock is neither overbought or oversold.

Conclusion: Is Blonder Tongue Laboratories, Inc. [BDR] a Reliable Buy?

Blonder Tongue Laboratories, Inc. [BDR] stock is presenting a less attractive investment opportunity when compared to similarly-sized corporations in the same industry. The price performance of these shares has not shown much promise, and the financial results that this company has recently delivered present a highly risky investment.